Molecular Diagnostics Market Research Report
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
List of Figures<br />
119. Total Number of Companies Profiled<br />
120. Abbott Laboratories: Overall Product Portfolio<br />
121. Abbott Laboratories: Overall Financials, 2015-2017<br />
122. Abbott Laboratories: Revenue (by Segment), 2015-<br />
2017<br />
123. Abbott Laboratories: Revenue Split for <strong>Diagnostics</strong>,<br />
2015-2017<br />
124. Abbott Laboratories: Revenue (by Region), 2015-<br />
2017<br />
125. Abbott Laboratories: R&D Expenditure, 2015-2017<br />
126. Abbott Laboratories: Revenue Forecast, 2015-2020<br />
127. Abbott Laboratories: SWOT Analysis<br />
128. Agilent Technologies, Inc.: Overall Product Portfolio<br />
129. Agilent Technologies, Inc.: Overall Financials, 2015-<br />
2017<br />
130. Agilent Technologies, Inc.: Revenue (by Segment),<br />
2015-2017<br />
131. Agilent Technologies, Inc.: Revenue (by Region),<br />
2015-2017<br />
132. Agilent Technologies, Inc.: R&D Expenditure, 2015-<br />
2017<br />
133. Agilent Technologies, Inc.: Revenue Forecast, 2015-<br />
2020<br />
134. Agilent Technologies, Inc.: SWOT Analysis<br />
135. Becton, Dickinson and Company: Overall Product<br />
Portfolio<br />
136. Becton, Dickinson and Company: Overall Financials,<br />
2015-2017<br />
137. Becton, Dickinson and Company: Revenue (by<br />
Segment), 2015-2017<br />
138. Becton, Dickinson and Company: Revenue Split for<br />
BD Life Sciences, 2015-2017<br />
139. Becton, Dickinson and Company: Revenue (by<br />
Region), 2015-2017<br />
140. Becton, Dickinson and Company: R&D Expenditure,<br />
2015-2017<br />
141. Becton, Dickinson and Company: Revenue<br />
Forecast, 2015-2020<br />
142. Becton, Dickinson and Company: SWOT Analysis<br />
143. bioMérieux S.A.: Overall Product Portfolio<br />
144. bioMérieux S.A.: Overall Financials, 2015-2017<br />
145. bioMérieux S.A.: Revenue (by Segment), 2015-2017<br />
146. bioMérieux S.A.: Revenue (by Region), 2015-2017<br />
147. bioMérieux S.A.: R&D Expenditure, 2015-2017<br />
148. bioMérieux S.A.: Revenue Forecast, 2015-2020<br />
149. bioMérieux S.A.: SWOT Analysis<br />
150. Bio-Rad Laboratories, Inc.: Overall Product Portfolio<br />
151. Bio-Rad Laboratories, Inc.: Overall Financials, 2015-<br />
2017<br />
152. Bio-Rad Laboratories, Inc.: Revenue (by Segment),<br />
2015-2017<br />
153. Bio-Rad Laboratories, Inc.: Revenue (by Region),<br />
2015-2017<br />
154. Bio-Rad Laboratories, Inc.: R&D Expenditure, 2015-<br />
2017<br />
155. Bio-Rad Laboratories, Inc.: SWOT Analysis<br />
156. Cynvenio Biosystems, Inc.: Overall Product Portfolio<br />
157. Cynvenio Biosystems, Inc.: SWOT Analysis<br />
158. Danaher Corporation: Overall Product Portfolio<br />
159. Danaher Corporation: Overall Financials, 2015-2017<br />
160. Danaher Corporation: Revenue (by Segment), 2015-<br />
2017<br />
161. Danaher Corporation: Revenue Split for <strong>Diagnostics</strong>,<br />
2015-2017<br />
162. Danaher Corporation: Revenue (by Region), 2015-<br />
2017<br />
163. Danaher Corporation: R&D Expenditure, 2015-2017<br />
164. Danaher Corporation: Revenue Forecast, 2015-2020<br />
165. Danaher Corporation: SWOT Analysis<br />
166. F. Hoffmann-La Roche AG: Overall Product Portfolio<br />
167. F. Hoffmann-La Roche AG: Overall Financials, 2015-<br />
2017<br />
168. F. Hoffmann-La Roche AG: Revenue (by Segment),<br />
2015-2017<br />
169. F. Hoffmann-La Roche AG: Revenue Split for<br />
<strong>Diagnostics</strong>, 2015-2017<br />
170. F. Hoffmann-La Roche AG: Revenue (by Region),<br />
sales@bisresearch.com | www.bisresearch.com
Change language